Intellia Therapeutics Announces First Quarter 2023 Financial Results and Highlights Recent Company ProgressGlobeNewsWire • 05/04/23
Intellia Therapeutics Releases 2023 Corporate Responsibility Report Highlighting the Advancement of its Environmental, Social & Governance (ESG) PrioritiesGlobeNewsWire • 05/01/23
Intellia Therapeutics to Hold Conference Call to Discuss First Quarter 2023 Earnings and Company UpdatesGlobeNewsWire • 04/27/23
Cathie Wood Loads Up On Biotech Stocks — Continues To Raise Stake In Coinbase GlobalBenzinga • 04/06/23
Intellia Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to NTLA-2002 for the Treatment of Hereditary AngioedemaGlobeNewsWire • 03/21/23
Intellia Therapeutics: Progressing Pipeline Signals Positive Outlook For InvestorsSeeking Alpha • 03/08/23
Intellia Therapeutics Stock Surges On A First-Ever In CRISPR Gene EditingInvestors Business Daily • 03/02/23